SEC Form 4 · accession 0001179110-19-003459

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Mar 4, 2019

Accepted (ET)

Mar 6, 2019 · 6:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 4, 2019	M	13,281	—	A	617,000	D
Common Stock^F1	Mar 4, 2019	A	13,944	—	A	630,944	D
Common Stock^F2	Mar 4, 2019	F	13,060	$67.55	D	617,884	D
Common Stock^F1	Mar 6, 2019	M	12,500	—	A	630,384	D
Common Stock^F2	Mar 6, 2019	F	6,192	$60.62	D	624,192	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F3	—	Mar 4, 2019	M	13,281	D	—	—	Common Stock	13,281	26,561	D
Restricted Stock Units^F4,F5	—	Mar 4, 2019	A	50,333	A	—	—	Common Stock	50,333	50,333	D
Restricted Stock Units^F1,F6	—	Mar 6, 2019	M	12,500	D	—	—	Common Stock	12,500	25,000	D
Restricted Stock Units^F4,F7	—	Mar 4, 2019	A	27,890	A	—	—	Common Stock	27,890	27,890	D

F1Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
F3On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F4Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F5The restricted stock unit vests in three equal annual installments beginning March 4, 2020.
F6On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018.
F7The restricted stock unit vests in two equal annual installments beginning March 1, 2020.